Toward an international consensus-Integrating lipoprotein apheresis and new lipid-lowering drugs
NHLBI Working Group Recommendations to Reduce Lipoprotein(a)-Mediated Risk of Cardiovascular Disease and Aortic Stenosis
Triciribine increases LDLR expression and LDL uptake through stabilization of LDLR mRNA
Inhibitors of AKT kinase increase LDL receptor mRNA expression by two different mechanisms
Guidelines on the Use of Therapeutic Apheresis in Clinical Practice-Evidence-Based Approach from the Writing Committee of the American Society for Apheresis: The Seventh Special Issue
Copyright © 2020 Ayma Therapeutics Inc. - All Rights Reserved.